Vaccination is undoubtedly one of the most remarkable health achievements in human history. In just over two centuries, vaccines have enabled us to achieve extraordinary goals, such as eradicating smallpox, eradicating polioRead More…
The mRNA COVID-19 vaccine has allowed us to witness the effectiveness, safety, and tremendous potential of mRNA technology. Currently, research institutions worldwide are targeting cancer as the next goal for mRNA technology.Read More…
GSK announced that its respiratory syncytial virus (RSV) vaccine Arexvy (RSVPreF3 OA/GSK3844766A) has been approved by the FDA for the prevention of lower respiratory disease (RSV-LRTD) caused by RSV infection in theRead More…
Traditional vaccines are committed to the prevention of a variety of infectious diseases, while cancer vaccines, which have attracted much attention in recent years, aim to focus the strength of the humanRead More…